LUCID DIAGNOSTICS INC.

Analyst Reco. Lucid Diagnostics Inc.

Equities

LUCD

US54948X1090

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-19 pm EDT			5-day change	1st Jan Change
0.7965 ^USD	-0.31%		-1.55%	-43.51%

Mar. 27	Cantor Fitzgerald Trims Price Target on Lucid Diagnostics to $3 From $3.80, Maintains Overweight Rating	MT
Mar. 26	Transcript : Lucid Diagnostics Inc., Q4 2023 Earnings Call, Mar 26, 2024

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cantor Fitzgerald Trims Price Target on Lucid Diagnostics to $3 From $3.80, Maintains Overweight Rating	Mar. 27	MT
Needham Adjusts Price Target on Lucid Diagnostics to $2.80 From $2.60, Maintains Buy Rating	23-05-17	MT
BTIG Adjusts Lucid Diagnostics' Price Target to $3.50 From $5, Keeps Buy Rating	22-11-18	MT
Needham Adjusts Price Target on Lucid Diagnostics to $3.10 From $4.25, Maintains Buy Rating	22-11-15	MT
Needham Cuts Price Target on Lucid Diagnostics to $4.25 From $5, 2023 Revenue Estimate to $15 Million From $20.8 Million; Buy Rating Kept	22-08-16	MT
Needham Adjusts Lucid Diagnostics' Price Target to $5 From $7 on 'Peer Multiple Compression,' Reiterates Buy Rating	22-05-12	MT
Canaccord Genuity Adjusts Lucid Diagnostics' Price Target to $12 From $18, Reiterates Buy Rating	22-03-29	MT
Needham Adjusts Lucid Diagnostics' Price Target to $7 From $13, Citing Peer Multiple Compression, Lowered Revenue Expectation; Buy Rating Kept	22-03-29	MT
Ascendiant Capital Starts Lucid Diagnostics at Buy With $16 Price Target	21-12-27	MT
Needham Lowers Lucid Diagnostics' Price Target to $13 From $17, Citing 'Peer Multiple Contraction;' Buy Rating Kept	21-12-15	MT
Canaccord Genuity Initiates Lucid Diagnostics at Buy Rating With $18 Price Target	21-11-08	MT
BTIG Starts Lucid Diagnostics at Buy with $14 Price Target	21-11-08	MT
Cantor Fitzgerald Starts Lucid Diagnostics at Overweight With $21 Price Target	21-11-08	MT
Needham Starts Lucid Diagnostics at Buy With $17 Price Target	21-11-08	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer